A. Jörres

B. Rutkowski, T. Liberek, T. Stompór, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Review Interleukin-17: a mediator of inflammatory responses

A. Jörres, J. Witowski, K. Ksia, 2004 .

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 2: renal replacement therapy.

W. van Biesen, R. Vanholder, A. Lewington, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

PROGRESS IN UREMIC TOXIN RESEARCH: Conservative Treatment of the Uremic Syndrome

C. Wanner, D. Fliser, Z. Massy, 2009, Seminars in dialysis.

Nightly Intermittent Peritoneal Dialysis: Targets and Prescriptions

A. Jörres, G. Gahl, G. Gahl, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Quality Assurance in Peritoneal Dialysis

A. Jörres, J. Witowski, C. Lage, 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Oxidative stress‐dependent increase in ICAM‐1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium

D. Dragun, G. Dworacki, K. Książek, 2010, International journal of cancer.

Lactate based Scoring System in the diagnosis of necrotizing fasciitis.

R. Lefering, J. Schiefer, A. Jörres, 2021, Journal of burn care & research : official publication of the American Burn Association.

Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial

W. Gaus, B. Rutkowski, D. Krieter, 1999, The Lancet.

Technological Advances in Peritoneal Dialysis Research Peritoneal Cell Culture: Fibroblasts

A. Jörres, J. Witowski, 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

TECHNOLOGICAL ADVANCES IN PERITONEAL DIALYSIS RESEARCH

A. Jörres, J. Witowski, 2006 .

Correlation between HSP-72 Expression and IL-8 Secretion in Human Mesothelial Cells

K. Herkner, A. Jörres, C. Aufricht, 2007, The International journal of artificial organs.

Glucose-Induced Mesothelial Cell Senescence and Peritoneal Neoangiogenesis and Fibrosis

K. Książek, A. Jörres, J. Witowski, 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

In Vitro Superiority of Dual-Chambered Peritoneal Dialysis Solution with Possible Clinical Benefits

M. Pischetsrieder, A. Jörres, J. Passlick–Deetjen, 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

First In Vitro and In Vivo Experiences with Stay·Safe Balance, A pH-Neutral Solution in a Dual-Chambered Bag

M. Pischetsrieder, A. Jörres, C. Aufricht, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The prevalence of incipient tubular dysfunction, but not of glomerular dysfunction, is increased in patients with diabetes onset in childhood.

W. Hopfenmüller, O. Kordonouri, T. Danne, 1999, Journal of diabetes and its complications.

Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network.

M. Eberl, P. Rutherford, R. Beelen, 2017, Kidney international.

Novel Peritoneal Dialysis Solutions – What Are the Clinical Implications?

A. Jörres, 2012, Blood Purification.

Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.

T. Liberek, G. Coles, N. Topley, 1993, Nephron.

Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus.

O. Kordonouri, C. Müller, A. Jörres, 1992, Scandinavian journal of clinical and laboratory investigation.

Serial measurement of neuron specific enolase improves prognostication in cardiac arrest patients treated with hypothermia: A prospective study

C. Ploner, C. Leithner, C. Storm, 2012, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest

C. Storm, A. Jörres, D. Hasper, 2011, Emergency Medicine Journal.

Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis

U. Frei, A. Jörres, C. Aufricht, 2008, Pediatric Nephrology.

Biocompatibility of Peritoneal Dialysis Fluids

N. Topley, A. Jörres, G. Gahl, 1992, The International journal of artificial organs.

Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines.

E. Stylianou, M. Davies, G. Coles, 1994, Kidney international.

Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells.

K. Książek, J. Mikuła-Pietrasik, A. Jörres, 2008, Free radical biology & medicine.

Systemic liberation of interleukin‐ 1β and interleukin‐1 receptor antagonist in the perioperative phase of liver transplantation

P. Neuhaus, J. Gerlach, M. Schön, 1996 .

Transfuse or not transfuse in acute renal failure? This is the question

M. Oppert, A. Jörres, 2005, Intensive Care Medicine.

Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha.

J. Westwick, M. Davies, G. Coles, 1993, The American journal of pathology.

Control of neutrophil influx during peritonitis by transcriptional cross‐regulation of chemokine CXCL1 by IL‐17 and IFN‐γ

M. Eberl, K. Eckardt, D. Dragun, 2020, The Journal of pathology.

Role of mesothelial cell-derived granulocyte colony-stimulating factor in interleukin-17-induced neutrophil accumulation in the peritoneum.

K. Pawlaczyk, K. Książek, C. Warnecke, 2007, Kidney international.

IL-17 Stimulates Intraperitoneal Neutrophil Infiltration Through the Release of GROα Chemokine from Mesothelial Cells1

H. Friess, K. Pawlaczyk, U. Frei, 2000, The Journal of Immunology.

Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report

J. Schefold, W. Witte, C. Storm, 2007, Journal of medical case reports.

Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA.

G. Coles, N. Topley, A. Jörres, 1996, Kidney international.

Timing of Acute Renal Replacement Therapy

A. Jörres, 2016 .

Effects of Dialysis Modality on Blood Loss, Bleeding Complications and Transfusion Requirements in Critically Ill Patients with Dialysis-Dependent Acute Renal Failure

J. Schefold, S. von Haehling, W. Doehner, 2015, Anaesthesia and intensive care.

Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort Study

P. von Landenberg, A. Jörres, Ana Harth, 2022, Journal of clinical medicine.

Organ Crosstalk in Critically Ill Patients: Hemofiltration and Immunomodulation in Sepsis

J. Schefold, A. Jörres, D. Hasper, 2009, Blood Purification.

Inhaled nitric oxide for ARDS due to sickle cell disease.

K. Eckardt, U. Kaisers, M. Oppert, 2004, Swiss medical weekly.

Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study

T. Friede, M. Addo, T. Rauen, 2020, Journal of clinical medicine.

Anesthesia in Patients with Kidney Failure

A. Jörres, D. Jörres, 2010 .

Thy-1+/- fibroblast subsets in the human peritoneum.

D. Dragun, A. Jörres, C. Schmitt, 2017, American journal of physiology. Renal physiology.

Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?

C. Storm, A. Jörres, 2008, Critical care.

Use of target temperature management after cardiac arrest in Germany--a nationwide survey including 951 intensive care units.

C. Leithner, C. Storm, A. Jörres, 2014, Resuscitation.

Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose.

K. Książek, A. Bręborowicz, A. Jörres, 2007, Free radical biology & medicine.

Effects of blood-dialyser interaction on prostaglandins in uraemic patients and in healthy man.

R. Hiss, A. Jörres, M. Kessel, 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Extracorporeal Therapies and Immunomodulation During Sepsis

J. Schefold, A. Jörres, J. Schefold, 2010 .

Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-β1

K. Książek, A. Jörres, J. Witowski, 2007, Laboratory Investigation.

Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence.

M. Zabel, K. Piwocka, K. Książek, 2006, Journal of applied physiology.

Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry.

R. Fanelli, C. Chiabrando, A. Jörres, 1993, Clinical chemistry.

Leukotriene Release from Neutrophils of Patients on Hemodialysis with Cellulose Membranes

A. Jörres, G. Gahl, A. Mahiout, 1992, The International journal of artificial organs.

Systemic liberation of interleukin‐8 in the perioperative phase of liver transplantation

P. Neuhaus, J. Gerlach, A. Jörres, 1997 .

Effect of Peritoneal Dialysis Fluids on Leukocyte Function

A. Jörres, G. Gahl, G. Gahl, 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Impact of Peritoneal Dialysis Solutions on Peritoneal Immune Defense

T. Liberek, N. Topley, A. Jörres, 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

New Insights into the Biology of Peritoneal Mesothelial Cells: The Roles of Epithelial-to-Mesenchymal Transition and Cellular Senescence

K. Książek, A. Jörres, J. Witowski, 2008, Nephron Experimental Nephrology.

Aus der Klinik für Nephrologie und Internistische Intensivmedizin der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Functional characterization of human peritoneal fibroblasts: implications for peritoneal immunity in patients treated with peritoneal dialysis

D. Dragun, A. Jörres, Hironori Tayama, 2018 .

Regulation of Chemokine CCL5 Synthesis in Human Peritoneal Fibroblasts: A Key Role of IFN-γ

D. Dragun, A. Jörres, J. Witowski, 2014, Mediators of inflammation.

Activation of nuclear factor of activated T cells 5 in the peritoneal membrane of uremic patients.

G. Ott, N. Braun, S. Segerer, 2015, American journal of physiology. Renal physiology.

Cyclosporine A-Induced Conchal Hyperplasia with Nasal Obstruction in a Patient with Membranous Nephropathy

A. Jörres, Ana Harth, F. Tillmann, 2022, The American journal of case reports.

Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains.

T. von Zglinicki, K. Książek, J. Mikuła-Pietrasik, 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα

W. Luttmann, K. Thierauch, M. Davies, 1993 .

Prävention der akuten Nierenschädigung beim kritisch kranken Patienten

A. Zarbock, W. Druml, M. Joannidis, 2018, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[Acute kidney injury: choice of the initial modality for renal replacement therapy].

A. Jörres, 2015, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

[S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations].

A. Weyland, T. Welte, R. Rossaint, 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.

T. Liberek, G. Coles, N. Topley, 1993, Journal of the American Society of Nephrology : JASN.

New insights into the management of hepato‐renal syndrome

A. Jörres, D. Hasper, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Akutes Nierenversagen

U. Frei, A. Jörres, 2001, Der Internist.

[Dose adjustment of anti-infective drugs in patients with renal failure and renal replacement therapy in intensive care medicine : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

A. Zarbock, M. Joannidis, J. Kielstein, 2018, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

Mesothelial Toxicity of Peritoneal Dialysis Fluids is Related Primarily to Glucose Degradation Products, Not to Glucose Per Se

K. Książek, A. Bręborowicz, A. Jörres, 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[Acute kidney failure].

U. Frei, A. Jörres, 2001, Der Internist.

The Role of the Glyoxalase Pathway in Reducing Mesothelial Toxicity of Glucose Degradation Products

A. Jörres, J. Witowski, K. Korybalska, 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Hashimoto’s Thyroiditis-Associated Acute Renal Failure and Pitfalls of eGFR Interpretation in Thyroid Diseases

A. Jörres, Ana Harth, F. Tillmann, 2021, European journal of case reports in internal medicine.

Peritoneal dialysis fluid biocompatibility: does it really matter?

U. Frei, A. Jörres, G. Gahl, 1994, Kidney international. Supplement.

Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: a key role of IL-1β stimulation

K. Książek, A. Jörres, J. Witowski, 2009, Laboratory Investigation.

Effect of glucose degradation products on human peritoneal mesothelial cell function.

U. Frei, A. Bręborowicz, A. Jörres, 2000, Journal of the American Society of Nephrology : JASN.

A Rare Cause of Left Shoulder Pain in a Peritoneal Dialysis Patient

A. Jörres, Ana Harth, F. Tillmann, 2021, The American journal of case reports.

[S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version].

A. Weyland, T. Welte, R. Rossaint, 2020, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

Systemic liberation of interleukin-1β and interleukin-1 receptor antagonist in the perioperative phase of liver transplantation

P. Neuhaus, J. Gerlach, M. Schön, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Administration of prostacyclin after liver transplantation: a placebo controlled randomized trial

U. Neumann, U. Settmacher, W. Bechstein, 2000, Clinical transplantation.

Local liberation of cytokines during liver preservation

P. Neuhaus, J. Gerlach, K. Zeilinger, 1999, Transplant international : official journal of the European Society for Organ Transplantation.

Review on uremic toxins: classification, concentration, and interindividual variability.

Raymond Vanholder, Peter Stenvinkel, Ciro Tetta, 2003, Kidney international.

Management of patients at risk of acute kidney injury

J. Kielstein, A. Jörres, W. Biesen, 2017, The Lancet.

Interleukin-17: a mediator of inflammatory responses

K. Książek, A. Jörres, J. Witowski, 2004, Cellular and Molecular Life Sciences CMLS.

Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines.

U. Frei, J. Langrehr, A. Jörres, 2001, The American journal of pathology.

Systemic liberation of interleukin-8 in the perioperative phase of liver transplantation

P. Neuhaus, M. Schön, A. Jörres, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Epithelial-to-Mesenchymal Transition and Migration of Human Peritoneal Mesothelial Cells Undergoing Senescence

A. Jörres, J. Witowski, P. Sandoval, 2019, Peritoneal Dialysis International.

IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives

A. Jörres, J. Kamhieh-Milz, J. Witowski, 2018, Front. Physiol..

PD membrane: biological responses to different PD fluids.

A. Jörres, J. Witowski, 2006, Contributions to nephrology.

Glucose Degradation Products: Relationship with Cell Damage

A. Jörres, J. Witowski, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.

C. Holmes, N. Topley, A. Jörres, 1996, Journal of the American Society of Nephrology : JASN.

Quality of design and reporting of animal research in peritoneal dialysis: A scoping review

I. Miechowicz, A. Bręborowicz, A. Jörres, 2020, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial

J. Kellum, C. Putensen, N. Weiler, 2017, PloS one.

PD: a biological membrane and a non-biological fluid.

A. Jörres, 2003, Contributions to nephrology.

IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane.

C. Fielding, Simon A. Jones, D. Dragun, 2017, Journal of the American Society of Nephrology : JASN.

Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.

U. Frei, A. Jörres, J. Passlick–Deetjen, 1998, Kidney international.

In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis.

U. Frei, A. Jörres, J. Passlick–Deetjen, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass.

O. Kordonouri, S. Farke, A. Schiessler, 1994, Artificial organs.

Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass.

O. Kordonouri, S. Farke, C. Chiabrando, 1992, Eicosanoids.

Extracorporeal thromboxane release and the morphological structure of artificial membrane after blood exposure.

A. Jörres, M. Kessel, H. Meinhold, 1988, Kidney international. Supplement.

Prostaglandin production and extracorporeal complement activation by dialyzer membranes.

A. Jörres, M. Kessel, H. Meinhold, 1986, ASAIO transactions.

Eicosanoid release as laboratory indicator of biocompatibility.

A. Jörres, G. Schultze, M. Kessel, 1989, Artificial organs.

Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.

N. Topley, U. Frei, A. Jörres, 1996, Journal of the American Society of Nephrology : JASN.

Recovery of senescent endothelial cells from injury.

A. Kusch, D. Dragun, A. Bręborowicz, 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)

M. Bauer, A. Weyland, U. Jaschinski, 2021, Critical care explorations.

In Vitro Studies on the Effect of Dialysis Solutions on Peritoneal Leukocytes

U. Frei, A. Jörres, G. Gahl, 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

PD and loss of peritoneal function.

A. Jörres, J. Witowski, T. O. Bender, 2007, Prilozi.

In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.

N. Topley, C. Müller, A. Jörres, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytokine Networks in Continuous Ambulatory Peritoneal Dialysis: Interactions of Resident Cells during Inflammation in the Peritoneal Cavity

M. Davies, John D. Williams, N. Topley, 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.

E. Köttgen, N. Topley, C. Müller, 1992, American journal of nephrology.

Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate.

E. Köttgen, C. Müller, A. Jörres, 1991, Nephron.

Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions.

N. Topley, A. Jörres, G. Gahl, 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.

John D. Williams, G. Coles, N. Topley, 1996, Kidney international.

Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.

T. Liberek, G. Coles, N. Topley, 1995, Kidney international.

Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.

U. Frei, A. Bręborowicz, A. Jörres, 2001, Journal of the American Society of Nephrology : JASN.

Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.

J. Briggs, N. Topley, J. Brock, 1996, Kidney international.

Patients' expressions of complaints as a predictor of the course of acute hepatitis A.

B. Klapp, M. Rose, A. Jörres, 2000, Journal of psychosomatic research.

Side Effects of Hybrid Liver Support Therapy: TNF-α Liberation in Pigs, Associated with Extracorporeal Bioreactors

J. Vienken, P. Neuhaus, J. Gerlach, 1993, The International journal of artificial organs.

Innovative approaches to the preservation of the peritoneal membrane: from bench to bedside.

A. Jörres, 2001, Advances in renal replacement therapy.

Comparison of Icodextrin- and Glucose-Based Peritoneal Dialysis Fluids in Their Acute and Chronic Effects on Human Peritoneal Mesothelial Cells

A. Jörres, J. Witowski, T. O. Bender, 2007, The International journal of artificial organs.

Is Introduction of the Bicarbonate Buffer in Pd Solution Una Voidable?

A. Jörres, 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Glucose degradation products in peritoneal dialysis fluids: do they harm?

K. Książek, A. Bręborowicz, A. Jörres, 2003, Kidney international. Supplement.

Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha.

W. Luttmann, K. Thierauch, M. Davies, 1993, Kidney international.

HSP Induction in Mesothelial Cells by Peritoneal Dialysis Fluid Depends on Biocompatibility Test System

A. Jörres, C. Aufricht, K. Kratochwill, 2011, The International journal of artificial organs.

Glucose Degradation Products in Peritoneal Dialysis: From Bench to Bedside

A. Jörres, 2003, Kidney and Blood Pressure Research.

Injury-Induced Inflammation and Inadequate HSP Expression in Mesothelial Cells upon Repeat Exposure to Dual-Chamber Bag Peritoneal Dialysis Fluids

A. Jörres, C. Aufricht, K. Kratochwill, 2015, The International journal of artificial organs.

Cross-Omics Comparison of Stress Responses in Mesothelial Cells Exposed to Heat- versus Filter-Sterilized Peritoneal Dialysis Fluids

K. Bialas, A. Jörres, C. Aufricht, 2015, BioMed research international.

Lessons from Basic Research for Pd Treatment

A. Jörres, J. Witowski, 2005, Peritoneal Dialysis International.

Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: Clinical Consequences

A. Jörres, J. Witowski, 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The peritoneal fibroblast and the control of peritoneal inflammation.

U. Frei, A. Jörres, G. Gahl, 1996, Kidney international. Supplement.

Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells.

A. Wieslander, A. Jörres, C. Aufricht, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Medihoney: let nature do the work?

W. van Biesen, A. Jörres, 2014, The Lancet. Infectious diseases.

Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.

J. Vienken, C. Müller, A. Jörres, 2008, Artificial organs.

Variables Associated with the Assessment of Systemic Tumor Necrosis Factor Alpha Levels during Hemodialysis

J. Vienken, C. Müller, A. Jörres, 1992, The International journal of artificial organs.

Effect of peritoneal dialysis on peritoneal cell biology: peritoneal fibroblasts.

A. Jörres, 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.

A. Tauer, T. Niwa, M. Pischetsrieder, 2005, Molecular nutrition & food research.

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating.

W. van Biesen, A. Jörres, 2014, Kidney international.

Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms.

N. Topley, P. Scholz, U. Frei, 1997, Cytokine.

Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation.

C. Storm, A. Jörres, D. Hasper, 2014, International journal of cardiology.

Simplified lung ultrasound protocol shows excellent prediction of extravascular lung water in ventilated intensive care patients

S. Rademacher, A. Jörres, D. Hasper, 2015, Critical Care.

Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury.

F. Frey, P. Hunziker, D. Uehlinger, 2014, Kidney international.

Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls

J. Schefold, M. Oppert, C. Storm, 2008, Critical care.

Preventing Peritoneal Fibrosis — An ACE up our Sleeve?

A. Jörres, J. Witowski, 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients

C. Putensen, N. Weiler, C. Engel, 2013, Critical Care.

Fatal acute diclofenac-induced immune hemolytic anemia

A. Seltsam, A. Jörres, J. Jürgensen, 2001, Annals of Hematology.

Acute Renal Replacement Therapy

A. Davenport, W. van Biesen, M. Oppert, 2011, International journal of nephrology.

[Quality improvement measures in the care of critically ill intensive care patients with renal replacement therapy for acute kidney injury : Position paper of the Kidney Section of DIVI in collaboration with DGAI and DGIIN].

A. Zarbock, P. Heering, M. Oppert, 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

A. Zarbock, M. Joannidis, J. Kielstein, 2018, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

Extracorporeal Liver Support Therapy With Prometheus in Patients With Liver Failure in the Intensive Care Unit

M. Oppert, S. Rademacher, A. Jörres, 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Peritoneal dialysis catheter leakage following intermittent vacuum therapy

A. Weidemann, A. Jörres, Ana Harth, 2017, Clinical kidney journal.

Interleukin-17 stimulates intraperitoneal neutrophil infiltration through the release of the chemokine GROα from peritoneal mesothelial cells

H. Friess, K. Pawlaczyk, U. Frei, 2000, Critical Care.

Continuous Flow Peritoneal Dialysis: Solution Formulation and Biocompatibility

A. Jörres, C. Lage, Jutta Passlick‐Deetjen, 2001, Seminars in dialysis.

Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study

J. Schefold, S. von Haehling, C. Storm, 2009, Critical care.

Peritoneal cell culture: fibroblasts.

A. Jörres, J. Witowski, 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Prostaglandin E2, thromboxane B2, and leukotriene B4 release from peritoneal macrophages by different osmotic agents in nonuremic guinea pigs.

A. Jörres, G. Gahl, B. Kögel, 1988, ASAIO transactions.

Glucose Degradation Products and Peritoneal Membrane Function

U. Frei, A. Jörres, J. Witowski, 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Glucose Degradation Products and the Peritoneal Mesothelium

A. Jörres, J. Witowski, T. O. Bender, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Neutropenic Sepsis in the ICU: Outcome Predictors in a Two-Phase Model and Microbiology Findings

C. Schmitt, M. Oppert, S. Rademacher, 2016, Critical care research and practice.

The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial

J. Schefold, S. Haehling, A. Jörres, 2014, Critical Care.

Isoflurane Sedation on the ICU in Cardiac Arrest Patients Treated With Targeted Temperature Management: An Observational Propensity-Matched Study

C. Leithner, A. Krannich, C. Storm, 2017, Critical care medicine.

CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial

T. Slowinski, C. Spies, K. Träger, 2020, Trials.

Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis

S. Kazmierczak, A. Jörres, V. Muravsky, 2008, Clinical chemistry and laboratory medicine.

Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course.

K. Wernecke, C. Spies, S. Weber-Carstens, 2014, Journal of critical care.

Blood purification in sepsis

A. Jörres, 2018, Critical Care.

Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains.

T. von Zglinicki, K. Książek, J. Mikuła-Pietrasik, 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge

A. Weyland, Mathias W Pletz, C. Putensen, 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

Akutes Nierenversagen – Evidenzbasierte Therapie mit Nierenersatzverfahren – intermittierend vs. CRRT

A. Jörres, 2013, Anästhesiol Intensivmed Notfallmed Schmerzther.

Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation.

C. Storm, A. Jörres, D. Hasper, 2014, International journal of cardiology.

Choosing a Therapy Modality for Acute Renal Replacement Therapy

A. Jörres, D. Jörres, 2010 .

Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin.

G. Dworacki, K. Książek, J. Mikuła-Pietrasik, 2009, The American journal of pathology.

Effect of glucose degradation products on human peritoneal mesothelial cell function.

A. Bręborowicz, A. Jörres, J. Passlick–Deetjen, 2000, Journal of the American Society of Nephrology : JASN.

Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis

U. Frei, A. Jörres, C. Aufricht, 2008, Pediatric Nephrology.